PayPay Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.2K Buy
16
+1
+7% +$1.02K 0.47% 31
2026
Q1
$13.6K Sell
15
-5
-25% -$5.07K 0.47% 50
2025
Q4
$21.5K Buy
20
+5
+33% +$4.78K 0.63% 34
2025
Q3
$11.7K Buy
15
+3
+25% +$2.23K 0.42% 37
2025
Q2
$9.35K Sell
12
-1
-8% -$777 0.46% 39
2025
Q1
$10.8K Sell
13
-6
-32% -$4.99K 0.62% 36
2024
Q4
$14.7K Sell
19
-4
-17% -$3.31K 0.64% 34
2024
Q3
$20.4K Buy
23
+8
+53% +$7.19K 1.81% 13
2024
Q2
$13.6K Sell
15
-9
-38% -$7.2K 1.13% 13
2024
Q1
$18.7K Buy
24
+1
+4% +$712 0.93% 22
2023
Q4
$13.9K Sell
23
-2
-8% -$1.17K 0.68% 32
2023
Q3
$13.4K Buy
+25
New +$12.9K 0.61% 39

Other funds holding LLY

PayPay Securities's LLY Position: Q2 2026 in Review

PayPay Securities increased its Eli Lilly (LLY) stake by 6.7% in Q2 2026, buying an estimated $1.02K and bringing the position to 16 shares worth $19.2K. The position accounts for 0.47% of the portfolio, ranked #31.

PayPay Securities first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $21.5K in Q4 2025. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • PayPay Securities held 16 shares of Eli Lilly worth $19.2K as of Q2 2026.
  • PayPay Securities bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.47% of PayPay Securities's portfolio in Q2 2026, its #31 holding.
  • PayPay Securities first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • PayPay Securities's Eli Lilly position peaked at $21.5K in Q4 2025.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.